Growdon Whitfield B, Wolfberg Adam J, Feltmate Colleen M, Goldstein Donald P, Genest David R, Chinchilla Manuel E, Berkowitz Ross S, Lieberman Ellice S
Donald P. Goldstein, M.D., Trophoblastic Tumor Registry, New England Trophoblastic Disease Center, USA.
J Reprod Med. 2006 Nov;51(11):871-4.
To develop human chorionic gonadotropin (hCG) criteria that determine a patient's risk of developing persistent gestational trophoblastic neoplasia (GTN) or achieving remission after partial mole evacuation.
We used a database from the New England Trophoblastic Disease Center to analyze hCG levels from 284 women with partial molar pregnancies diagnosed between 1973 and 2003.
An hCG level >199 mIU/mL in the third through eighth week following molar evacuation was associated with at least a 35% risk of GTN.
Women with partial mole who have elevated hCG levels within the first few weeks after molar evacuation are at increased risk for developing GTN.
制定人绒毛膜促性腺激素(hCG)标准,以确定患者发生持续性妊娠滋养细胞肿瘤(GTN)或在部分葡萄胎清宫后实现缓解的风险。
我们使用了新英格兰滋养细胞疾病中心的数据库,分析了1973年至2003年间诊断为部分性葡萄胎妊娠的284名女性的hCG水平。
葡萄胎清宫后第三至第八周,hCG水平>199 mIU/mL与至少35%的GTN风险相关。
部分性葡萄胎女性在葡萄胎清宫后的头几周内hCG水平升高,发生GTN的风险增加。